Additional Xifaxan Indication and Dosage Strength Approved
3/26/2010 7:42:08 AM
The FDA has approved Salix Pharmaceuticals’ Xifaxan (rifaximin) 550 mg tablets for the risk reduction of overt hepatic encephalopathy recurrence in patients 18 years of age and older. The medication is also indicated for the treatment of traveler's diarrhea caused by noninvasive strains of Escherichia coli in patients 12 years of age and older. The company expects to begin shipping the product in early May 2010
Male, 22. Diagnosed with Crohn's officially since 2001.. Osteoporosis, Generalized Anxiety Disorder, Chronic Anemia.
Medications Used: Remicade, Humira, Cimzia, 6-mp, Pentasa, Flagyl, Prednisone, Zifaxan, Entocort,
TPN (Total Parenteral Nutrition), The whole nine.
Current: Methotrexate Injection, Entocort EC, Vitamin D, Fentanyl 25mcg / 72hrs - Zofran - Folic Acid
Currently On SSDI